Regarding plasma-derived von Willebrand factor concentrates: what about viral safety?

Résumé fourni par la source

We present a brief report on the status of viral safety of plasma derived factor concentrates (pd-FC), especially von Willebrand factor (VWF), in the 21 st century.We also present the results of the efforts of the manufacturers and the close observation of guidelines to produce plasma factor concentrates.These efforts and continuous monitoring of these processes allow us to reach a level of safety never achieved before.We remark that this continuous process is necessary to guarantee the safety of a product such as plasma, increasingly necessary in different areas of medicine, focusing on plasma concentrates of VWF (pdVWF).This control is need for products obtained by biotechnology, for which there is less experience.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.